National Institute of General Medical Sciences; Notice of Closed Meetings, 39741 [2013-15771]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 127 / Tuesday, July 2, 2013 / Notices
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jose H Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: HIV/AIDS Innovative Research
Applications.
Date: July 24, 2013.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Mark P Rubert, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1775, rubertm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 26, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–15768 Filed 7–1–13; 8:45 am]
BILLING CODE 4140–01–P
Dated: June 26, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–15771 Filed 7–1–13; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
tkelley on DSK3SPTVN1PROD with NOTICES
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; SCORE Grant Applications.
Date: July 23, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
16:48 Jul 01, 2013
Jkt 229001
Place: Hilton Garden Inn Washington DC/
Bethesda, 7301 Waverly Street, Bethesda, MD
20814.
Contact Person: Saraswathy Seetharam,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3An.12C,
Bethesda, MD 20892–4874, 301–594–2763,
seetharams@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel Complex Phenotypes.
Date: July 24–25, 2013.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3An.12, Bethesda, MD 20892–4874, (Virtual
Meeting).
Contact Person: Lisa A. Dunbar, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.12, Bethesda, MD
20892–4874, 301–594–2849,
dunbarl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Announcement of Agency Decision:
Recommendations on the Use of
Chimpanzees in NIH-Supported
Research
This notice announces the
responses to public comments and
decisions of the National Institutes of
Health (NIH) regarding the use of
chimpanzees in research. In February
2012, the NIH charged a working group
of the Council of Councils, a federal
advisory committee, to provide advice
on implementing recommendations
made by the Institute of Medicine (IOM)
Committee on the Use of Chimpanzees
in Biomedical and Behavioral Research
in its 2011 report, Chimpanzees in
Biomedical and Behavioral Research:
Assessing the Necessity. On January 22,
2013, the NIH Council of Councils
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
39741
(Council) accepted recommendations
presented by the Working Group on the
Use of Chimpanzees in NIH-Supported
Research and provided these
recommendations to the NIH. The NIH
subsequently issued a request for
comments to obtain broad public input
on the 28 Council recommendations
that the NIH is considering as it
determines how to implement the IOM
Committee’s recommendations. This
notice summarizes the comments
received in response to the request for
comments and announces the agency’s
decisions with respect to the Council
recommendations. The NIH plans to
prepare subsequent procedural guidance
and technical assistance, as appropriate,
to implement some of these decisions.
Investigators should continue to follow
existing guidance (see NOT–OD–12–025
at https://grants.nih.gov/grants/guide/
notice-files/NOT-OD-12-025.html)
regarding the submission of
applications, proposals, or protocols for
research involving chimpanzees until
the NIH announces the procedural
guidance.
FOR FURTHER INFORMATION CONTACT: The
Division of Program Coordination,
Planning, and Strategic Initiatives,
Office of the Director, National
Institutes of Health at
dpcpsi@od.nih.gov.
SUPPLEMENTARY INFORMATION:
Background
The use of animals in biomedical and
behavioral research has enabled
scientists to identify new ways to treat
illness, extend life, and improve health
and well-being. Chimpanzees are our
closest relatives in the animal kingdom,
providing exceptional insights into
human biology and requiring special
consideration and respect. Although
used very selectively and in limited
numbers for biomedical research,
chimpanzees have served an important
role in advancing human health.
However, new methods and
technologies developed by the
biomedical research community have
provided alternatives to the use of
chimpanzees in several areas of
research.
In December 2010, the National
Institutes of Health (NIH) commissioned
a study by the Institute of Medicine
(IOM) to assess whether chimpanzees
are or will be necessary for NIH-funded
biomedical and behavioral research. On
December 15, 2011, the IOM Committee
on the Use of Chimpanzees in
Biomedical and Behavioral Research
(IOM Committee) issued its findings
along with a primary recommendation
that a set of principles and criteria guide
E:\FR\FM\02JYN1.SGM
02JYN1
]]>Agencies
[Federal Register Volume 78, Number 127 (Tuesday, July 2, 2013)]
[Notices]
[Page 39741]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-15771]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; SCORE Grant Applications.
Date: July 23, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Washington DC/Bethesda, 7301 Waverly
Street, Bethesda, MD 20814.
Contact Person: Saraswathy Seetharam, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3An.12C, Bethesda, MD 20892-4874, 301-594-2763,
seetharams@nigms.nih.gov.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel Complex Phenotypes.
Date: July 24-25, 2013.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Room 3An.12, Bethesda, MD 20892-4874, (Virtual
Meeting).
Contact Person: Lisa A. Dunbar, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3An.12, Bethesda, MD 20892-4874, 301-594-2849,
dunbarl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National Institutes of Health, HHS)
Dated: June 26, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-15771 Filed 7-1-13; 8:45 am]
BILLING CODE 4140-01-P
